Elutia Inc. (ELUT) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of Elutia Inc. stock $2.65, price $0.9, upside +194.4%, quality 48 out of 100. Rating: strongly undervalued. Calculated from audited financials with 8 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Elutia Inc.
ELUT · USCheap (66% below fair value) and rising price, but weak company: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 22, 2026.
How to read this chart
60‑month range $0.505 – $9.23 · fair‑value band $1.99 – $3.31 · the $0.9 price screens below the $2.65 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 22, 2026.
Every Wednesday you see whether Elutia is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular.
Show moreShow less
Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction.
It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery.
In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature.
The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023.
Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
Stock analysis
Elutia Inc. (ELUT) currently trades at $0.9, while our model-based Fair Value estimate is $2.65, implying the stock looks roughly 66% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $19.98 per share, and 7 of the 8 models we run sit above the $0.9 price.
Bear case: the Asset-Based group reads lowest at $0.48, and 1 of the 8 models stay below the price. Data coverage for this calculation is low.
Scenario range: $1.99 (bear) to $3.31 (bull), the price of $0.9 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Elutia Inc. reported revenue of $12.3M in FY2025 versus $47.4M in FY2021, a compound −28.6%/yr. Reported net income was $53.4M in FY2025.
Key figures
Market cap $39.3M Micro · P/S ratio 2.94 · EPS (TTM) $-0.68 · Return on assets (EBIT) −56.8% (5-year average) · Operating margin −166% · Revenue (TTM) $13.6M · Revenue growth (quarter YoY) +20.4% · Free cash flow −$46.7M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 78% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at 194%, ELUT screens cheaper than that median.
Fair Value models
All 8 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, no officer or director bought or sold shares on the open market.
- BuyKevin RakinDirector, 10% owner70,000 shares at $1.06$74,200Jan 30, 2026
- BuyGuido J NeelsDirector2× since Jan 28, 2026: 50,000 shares, avg. $1.05$52,600Jan 30, 2026
- BuyHighCape Partners GP II, LLC10% owner50,000 shares at $0.5200$26,000Dec 17, 2025
- BuyMatthew FergusonCHIEF FINANCIAL OFFICER2× since Dec 1, 2025: 70,000 shares, avg. $0.5487$38,410Dec 17, 2025
- BuyC Randal MillsPRESIDENT AND CEO, Director2× since Nov 24, 2025: 8,000 shares, avg. $0.5663$4,530Dec 17, 2025
- BuyBrigid MakesDirector25,000 shares at $0.5200$13,000Dec 17, 2025
- BuyDavid ColpmanDirector12,500 shares at $0.5100$6,375Dec 17, 2025
Plus 8 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 20, 2026. All filings at the SEC ↗
Revenue & earnings trend
Watch ELUT, get fair value alerts →
Compare Elutia Inc. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 399 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Stryker Corporation SYK | $310.00 | $341.00 | +10% | vs ELUT |
| Boston Scientific Corporation BSX | $41.98 | $46.18 | +10% | vs ELUT |
| DexCom, Inc DXCM | $79.32 | $87.25 | +10% | vs ELUT |
| STERIS plc STE | $255.76 | $281.34 | +10% | vs ELUT |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥183.81 | ¥197.34 | +7% | vs ELUT |
| GE HealthCare Technologies Inc GEHC | $80.64 | $69.92 | −13% | vs ELUT |
| Edwards Lifesciences Corporation EW | $101.85 | $81.94 | −20% | vs ELUT |
| Medtronic plc MDT | $99.94 | $74.89 | −25% | vs ELUT |
| Abbott Laboratories, ABT | $103.00 | $75.28 | −27% | vs ELUT |
| Koninklijke Philips N.V PHIA | €26.39 | €15.23 | −42% | vs ELUT |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Elutia Inc. (ELUT) overvalued or undervalued?
What is the fair value of ELUT?
What is the quality score of ELUT?
What is the price target for Elutia Inc. (ELUT)?
What is the Elutia Inc. stock forecast for 2026?
What is the revenue of Elutia Inc. (ELUT)?
What is the intrinsic value of Elutia Inc. (ELUT)?
Is Elutia Inc. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of ELUT?
How much is Elutia Inc. worth?
What do the bullish and bearish scenarios say about ELUT?
How solid is the balance sheet of Elutia Inc. (ELUT)?
How far is ELUT from its 52-week high?
Which stocks are comparable to Elutia Inc.?
Is Elutia Inc. stock attractive at the current price?
How is the fair value of ELUT calculated?
Is it still worth investing in stocks now?
What is the share price of Elutia Inc. (ELUT)?
What should I pay attention to with Elutia Inc. right now?
Key figures of Elutia Inc.
How large is the market capitalisation of Elutia Inc. (ELUT)?
What is the P/S ratio of Elutia Inc. (ELUT)?
What are the earnings per share of Elutia Inc. (ELUT)?
What is the EBIT return on assets of Elutia Inc. (ELUT)?
What is the operating margin of Elutia Inc. (ELUT)?
How fast is revenue growing at Elutia Inc. (ELUT)?
How much free cash flow does Elutia Inc. (ELUT) generate?
How much net cash does Elutia Inc. (ELUT) hold?
Watch Elutia Inc. in the live analysis
One click puts Elutia Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.